| National Native HIV/AIDS Awareness Day  March 20: National Native HIV/AIDS Awareness Day National Native HIV/AIDS Awareness Day (NNHAAD) highlights the impact of HIV and AIDS in Native communities. The annual observance, celebrated on March 20th, is meant to increase awareness, start conversations, and spotlight the work being done to reduce HIV among American Indians, Alaska Natives, and Native Hawaiians, and show support for people with HIV in these communities. | | | | Clinical Info Releases Fact Sheets on Two New HIV Medicines – Vocabria and Cabenuva The Food and Drug Administration (FDA) recently approved Vocabria and Cabenuva for the treatment of HIV infection. Both medicines are for use in adults who meet certain requirements, as determined by a health care provider. - Vocabria is approved for use in combination with rilpivirine (brand name: Edurant) for the short-term treatment of HIV infection. Vocabria is an oral tablet that contains cabotegravir. Vocabria is used to see how well a person tolerates cabotegravir before they receive Cabenuva injections and may also be used if a person misses a planned injection of Cabenuva.
- Cabenuva is approved as a complete HIV treatment regimen. It's a long-acting injectable regimen that contains two different medicines: cabotegravir and rilpivirine. Cabenuva is always administered by a health care provider.
Do you want to learn more about HIV medicines? Check out the HIVinfo FDA-Approved HIV medicines fact sheet and infographic. | | | |
No comments:
Post a Comment